Weihang Bao

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.1K citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +5

Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults

Gerald S. Berenson, Sathanur R. Srinivasan, Weihang Bao et al. · New England Journal of Medicine · 1998 · 3.9K citations · Full text

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease

Paul Rutgeerts, Brian G. Feagan, Gary R. Lichtenstein et al. · Gastroenterology · 2004 · 947 citations

Inflammation, Episodic Treatment Strategies, Anti-inflammatory +4

Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: The Bogalusa heart study*

Weihang Bao, Sam A. Threefoot, Sathanur R. Srinivasan et al. · American Journal of Hypertension · 1995 · 765 citations

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

Paul Rutgeerts, Robert H. Diamond, Mohan Bala et al. · Gastrointestinal Endoscopy · 2006 · 546 citations

Inflammation, Anti-inflammatory, Maintenance Treatment +6